A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?
Patients with unresectable biliary tract carcinomas (BTCs) have a poor prognosis with a median overall survival of fewer than 12 months following systemic chemotherapy. In recent years, the identification of distinct molecular alterations with corresponding targeted therapies is modifying this thera...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Open Exploration Publishing Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/46affa1a81044e6ca6b2213bb2362c97 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|